Course: To Address Drug Affordability, Grab the Low-hanging Fruit
CME Credits: 1.00
Released: 2021-04-27
With COVID-19 dominating the news, it is easy to forget that up until a year ago, the US public’s were improving the affordability of health care and prescription drugs. But the need for action has only increased during the pandemic as millions of people in the US lost employer-sponsored insurance, states incurred massive expenses, and prescription drug prices continued their upward march.
Educational Objective
To identify the key insights or developments described in this article
View Full Course